Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SM360320 (CL-087) is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity. SM360320 can be used for research on acting as an immunological adjuv
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 197.00 | |
5 mg | In stock | $ 428.00 | |
10 mg | In stock | $ 639.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,370.00 | |
100 mg | In stock | $ 1,830.00 | |
500 mg | In stock | $ 3,690.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 473.00 |
Description | SM360320 (CL-087) is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity. SM360320 can be used for research on acting as an immunological adjuv |
Synonyms | CL-087, SM 360320, CL 087, 1V136, SM-360320, CL087 |
Molecular Weight | 315.33 |
Formula | C15H17N5O3 |
CAS No. | 226907-52-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (380.55 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SM360320 226907-52-4 Immunology/Inflammation TLR TLR7 1V-136 CL-087 Inhibitor Th1 Toll-like Receptor (TLR) SM 360320 antitumor effect 1V 136 CL 087 1V136 SM-360320 oral DNA vaccines inhibit CL087 inhibitor